BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kelly DM, Rothwell PM. Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines. Kidney Int 2020;97:266-78. [PMID: 31866114 DOI: 10.1016/j.kint.2019.09.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Wolfe R, Wetmore JB, Woods RL, McNeil JJ, Gallagher H, Roderick P, Walker R, Nelson MR, Reid CM, Shah RC, Ernst ME, Lockery JE, Tonkin AM, Abhayaratna WP, Gibbs P, Wood EM, Mahady SE, Williamson JD, Donnan GA, Cloud GC, Murray AM, Polkinghorne KR. Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease. Kidney Int 2021;99:466-74. [PMID: 32920022 DOI: 10.1016/j.kint.2020.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xu H, Garcia-Ptacek S, Trevisan M, Evans M, Lindholm B, Eriksdotter M, Carrero Pharm JJ. Kidney Function, Kidney Function Decline, and the Risk of Dementia in Older Adults: A Registry-Based Study. Neurology 2021:10. [PMID: 33952656 DOI: 10.1212/WNL.0000000000012113] [Reference Citation Analysis]
3 Kelly DM, Rothwell PM. Impact of multimorbidity on risk and outcome of stroke: Lessons from chronic kidney disease. Int J Stroke 2021;16:758-70. [PMID: 33243088 DOI: 10.1177/1747493020975250] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kimura A, Tanaka M, Moniwa N, Osanami A, Abe K, Miyamori D, Gocho Y, Shibata S, Terasawa M, Okazaki Y, Yamashita T, Koyama M, Furuhashi M, Ohnishi H, Miura T. Impact of atrial fibrillation on the risk of ischemic stroke in patients on hemodialysis: BOREAS-HD3 Study. Clin Exp Nephrol 2021;25:297-304. [PMID: 33206249 DOI: 10.1007/s10157-020-01991-9] [Reference Citation Analysis]
5 Barashi R, Hornik-Lurie T, Gabay H, Haskiah F, Minha S, Shuvy M, Assali A, Pereg D. Renal function and outcome of patients with non-valvular atrial fibrillation. Eur Heart J Acute Cardiovasc Care 2021:zuab075. [PMID: 34458895 DOI: 10.1093/ehjacc/zuab075] [Reference Citation Analysis]
6 Maeda T, Nishi T, Funakoshi S, Tada K, Tsuji M, Satoh A, Kawazoe M, Yoshimura C, Arima H. Increased Incident Ischemic Stroke Risk in Advanced Kidney Disease: A Large-Scale Real-World Data Study. Am J Nephrol 2020;51:659-68. [PMID: 32726780 DOI: 10.1159/000509567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zanoli L, Mikhailidis DP. Narrative Review of Carotid disease and the kidney. Ann Transl Med 2021;9:1210. [PMID: 34430651 DOI: 10.21037/atm-20-5001] [Reference Citation Analysis]
8 Chao CH, Wu CL, Huang WY. Association between estimated glomerular filtration rate and clinical outcomes in ischemic stroke patients with high-grade carotid artery stenosis. BMC Neurol 2021;21:124. [PMID: 33740899 DOI: 10.1186/s12883-021-02154-3] [Reference Citation Analysis]
9 Mark PB, Jhund PS, Walters MR, Petrie MC, Power A, White C, Robertson M, Connolly E, Anker SD, Bhandari S, Farrington K, Kalra PA, Tomson CRV, Wheeler DC, Winearls CG, McMurray JJV, Macdougall IC, Ford I. Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL Trial. Kidney360 2021;2:1761-9. [PMID: 35372992 DOI: 10.34067/KID.0004272021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shah B, Jagtap P, Sarmah D, Datta A, Raut S, Sarkar A, Bohra M, Singh U, Baidya F, Kalia K, Borah A, Dave KR, Yavagal DR, Bhattacharya P. Cerebro-renal interaction and stroke. Eur J Neurosci 2021;53:1279-99. [PMID: 32979852 DOI: 10.1111/ejn.14983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Matsuzaki K, Ohizumi Y. Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders. Nutrients 2021;13:E145. [PMID: 33406641 DOI: 10.3390/nu13010145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chavda V, Chaurasia B, Deora H, Umana GE. Chronic Kidney disease and stroke: A Bi-directional risk cascade and therapeutic update. Brain Disorders 2021;3:100017. [DOI: 10.1016/j.dscb.2021.100017] [Reference Citation Analysis]
13 Miglinas M, Cesniene U, Janusaite MM, Vinikovas A. Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients. Front Cardiovasc Med 2020;7:96. [PMID: 32582768 DOI: 10.3389/fcvm.2020.00096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]